Stefano Ugolini was born in 1987. He obtained a Bachelor Degree in Biomedical Engineering at the Politecnico di Milano in 2010 with a thesis on computational analyses of the Acetylcholine Receptor ion channel. In 2012 he obtained a Master Degree in Biotechnology at Kingston University (London). His final thesis work was carried out at and aimed at developing a novel gene therapy for Duchenne's Muscular Dystrophy. He is now enrolled as a PhD student in the Biomechanics Group at the Politecnico di Milano.